Prothymosin-α inhibits HIV-1 via toll-like receptor 4-mediated type I interferon induction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 22, 2010, Pages 10178-10183

  Mosoian, Arevik ^a   Teixeira, Avelino ^a   Burns, Colin S ^b   Sander, Leif E ^a   Gusella, G Luca ^a   He, Cijiang ^a   Magarian Blander, J ^a   Klotman, Paul ^a   Klotmana, Mary E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Macrophage; TIR domain containing adapter inducing interferon

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; PROTHYMOSIN ALPHA; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; INTERFERON INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID SEQUENCE; ANIMALS; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; HIV-1; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; LIGANDS; MACROPHAGES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; THYMOSIN; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77953406240     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914870107     Document Type: Article

References (32)

1. Mosoian A, Teixeira A, Caron E, Piwoz J, Klotman ME (2000) CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines. Viral Immunol 13:481-495. (Pubitemid 32063560)
2. Cocchi F, et al. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
3. Pal R, et al. (1997) Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 278:695-698. (Pubitemid 27464969)
4. Geiben-Lynn R, et al. (2001) Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines. J Virol 75:8306-8316. (Pubitemid 32743703)
5. Levy JA (2003) The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol 24:628-632.
6. Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS (1996) CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci USA 93: 15341-15345.
7. Mosoian A, et al. (2006) Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages. J Virol 80:9200-9206. (Pubitemid 44359992)
8. Hannappel E, Huff T (2003) The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: Structure and function. Vitam Horm 66:257-296.
9. Piñeiro A, Cordero OJ, Nogueira M (2000) Fifteen years of prothymosin alpha: Contradictory past and new horizons. Peptides 21:1433-1446.
10. Mosoian A, et al. (2007) Influence of prothymosin-alpha on HIV-1 target cells. Ann N Y Acad Sci 1112:269-285. (Pubitemid 47598678)
11. Wilson CL, Monteith WB, Danell AS, Burns CS (2006) Purification and characterization of the central segment of prothymosin-alpha: Methodology for handling highly acidic peptides. J Pept Sci 12:721-725.
12. Skopeliti M, et al. (2007) Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation. Proteomics 7:1814-1824. (Pubitemid 46911001)
13. Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19:24-32.
14. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122.
15. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738. (Pubitemid 33009951)
16. Apetoh L, et al. (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050-1059. (Pubitemid 47517504)
17. Midwood K, et al. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15:774-780.
18. Ohashi K, Burkart V, Flohé S, Kolb H (2000) Cutting edge: Heat shock protein 60 is aputative endogenous ligandof the toll-like receptor-4 complex. J Immunol 164:558-561. (Pubitemid 30043672)
19. Bozza S, et al. (2007) Thymosin alpha1 activates the TLR9/MyD88/IRF7- dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int Immunol 19:1261-1270. (Pubitemid 47604727)
20. Romani L, et al. (2004) Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 103:4232-4239. (Pubitemid 38685368)
21. Moody TW, et al. (2000) Thymosinalpha1 is chemopreventive for lung adenoma formation in A/J mice. Cancer Lett 155:121-127.
22. Nagai Y, et al. (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667-672. (Pubitemid 34752476)
23. Visintin A, Latz E, Monks BG, Espevik T, Golenbock DT (2003) Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J Biol Chem 278:48313-48320. (Pubitemid 37523286)
24. Shimazu R, et al. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189:1777-1782. (Pubitemid 29272694)
25. Viriyakosol S, Tobias PS, Kitchens RL, Kirkland TN (2001) MD-2 binds to bacterial lipopolysaccharide. J Biol Chem 276:38044-38051.
26. Gruber A, Mancek M, Wagner H, Kirschning CJ, Jerala R (2004) Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. J Biol Chem 279:28475-28482. (Pubitemid 38900129)
27. Mancek-Keber M, Jerala R (2006) Structural similarity between the hydrophobic fluorescent probe and lipid A as a ligand of MD-2. FASEB J 20:1836-1842. (Pubitemid 44933797)
28. Park BS, et al. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191-1195.
29. Gast K, et al. (1995) Prothymosin alpha: A biologically active protein with random coil conformation. Biochemistry 34:13211-13218.
30. Uversky VN, et al. (1999) Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH. Biochemistry 38:15009-15016. (Pubitemid 129517645)
31. Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014-1018.
32. Takeuchi O, et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451. (Pubitemid 29504199)